Quick Takeaways
- This page summarizes SMITH ALAN E's Form 3 filing for Candel Therapeutics, Inc. (CADL).
- 0 reported transactions and 3 derivative rows are listed below.
- Filing timestamp: 26 Jul 2021, 21:24.
SMITH ALAN E - 26 Jul 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)
- Role
- Director
- Signature
- /s/ Alan E. Smith
- Issuer symbol
- CADL
- Transactions as of
- 26 Jul 2021
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 26 Jul 2021, 21:24:52 UTC
- SEC
- View on sec.gov
Quoteable Key Fact
"SMITH ALAN E filed Form 3 for Candel Therapeutics, Inc. (CADL) on 26 Jul 2021."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Official SEC Source
See Original Filing
Ownership activity is grounded in SEC Form 3 disclosures.
Transactions Table
CADL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 32,548
- Date
- 26 Jul 2021
- Ownership
- Direct
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
CADL
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,068
- Exercise price
- $1.46
- Footnotes
- F1
CADL
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,274
- Exercise price
- $1.55
- Footnotes
- F2
CADL
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,274
- Exercise price
- $6.64
- Footnotes
- F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| F2 | This option is fully vested and exercisable as of the date hereof. |